Renee Donahue
0000-0002-6828-3073
1 paper found
Refreshing results…
First-in-human phase Ib trial of M9241 (NHS-IL12) plus avelumab in patients with advanced solid tumors, including dose expansion in patients with advanced urothelial carcinoma
Missing publications? Search for publications with a matching author name.